By proceeding, you agree to our Terms of Use and Privacy Policy.
xBiohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.
22-25 February 2022
Learn and collaborate with health professionals focused on advancing federal, public, and global health.
Event Ended
Virtual
Paid